Yuanzheng Xia

State Key Laboratory Of Natural Medicines
Nanjing, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications

Lung tumour secretome and extracellular vesicles: mechanisms, biomarkers, and therapeutic opportunities.

Lung tumour secretome and extracellular vesicles: mechanisms, biomarkers, and therapeutic opportunities.

Journal: Cancer metastasis reviews
Published: April 20, 2026

Cocrystal@protein-anchoring nanococktail for combinatorially treating multidrug-resistant cancer.

Cocrystal@protein-anchoring nanococktail for combinatorially treating multidrug-resistant cancer.

Journal: Acta pharmaceutica Sinica. B
Published: April 15, 2024

Overcoming Cancer Persister Cells by Stabilizing the ATF4 Promoter G-quadruplex.

Overcoming Cancer Persister Cells by Stabilizing the ATF4 Promoter G-quadruplex.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: February 20, 2024

Two types of coumarins-specific enzymes complete the last missing steps in pyran- and furanocoumarins biosynthesis.

Two types of coumarins-specific enzymes complete the last missing steps in pyran- and furanocoumarins biosynthesis.

Journal: Acta pharmaceutica Sinica. B
Published: August 11, 2023

Synthesis and biological evaluation of capsaicin analogues as antioxidant and neuroprotective agents.

Synthesis and biological evaluation of capsaicin analogues as antioxidant and neuroprotective agents.

Journal: RSC advances
Published: July 28, 2023

Discovery of Novel N-Heterocyclic-Fused Deoxypodophyllotoxin Analogues as Tubulin Polymerization Inhibitors Targeting the Colchicine-Binding Site for Cancer Treatment.

Discovery of Novel N-Heterocyclic-Fused Deoxypodophyllotoxin Analogues as Tubulin Polymerization Inhibitors Targeting the Colchicine-Binding Site for Cancer Treatment.

Journal: Journal of medicinal chemistry
Published: December 06, 2022

Improving cancer immunotherapy via co-delivering checkpoint blockade and thrombospondin-1 downregulator.

Improving cancer immunotherapy via co-delivering checkpoint blockade and thrombospondin-1 downregulator.

Journal: Acta pharmaceutica Sinica. B
Published: May 23, 2022

Iso-seco-tanapartholide activates Nrf2 signaling pathway through Keap1 modification and oligomerization to exert anti-inflammatory effects.

Iso-seco-tanapartholide activates Nrf2 signaling pathway through Keap1 modification and oligomerization to exert anti-inflammatory effects.

Journal: Free radical biology & medicine
Published: October 04, 2021

ATF4 destabilizes RET through nonclassical GRP78 inhibition to enhance chemosensitivity to bortezomib in human osteosarcoma.

ATF4 destabilizes RET through nonclassical GRP78 inhibition to enhance chemosensitivity to bortezomib in human osteosarcoma.

Journal: Theranostics
Published: May 19, 2019

A Purified Resin Glycoside Fraction from Pharbitidis Semen Induces Paraptosis by Activating Chloride Intracellular Channel-1 in Human Colon Cancer Cells.

A Purified Resin Glycoside Fraction from Pharbitidis Semen Induces Paraptosis by Activating Chloride Intracellular Channel-1 in Human Colon Cancer Cells.

Journal: Integrative cancer therapies
Published: January 08, 2019

Chrysanthemulide A induces apoptosis through DR5 upregulation via JNK-mediated autophagosome accumulation in human osteosarcoma cells.

Chrysanthemulide A induces apoptosis through DR5 upregulation via JNK-mediated autophagosome accumulation in human osteosarcoma cells.

Journal: Journal of cellular physiology
Published: September 06, 2018

DEAD Box Protein 5 Inhibits Liver Tumorigenesis by Stimulating Autophagy via Interaction with p62/SQSTM1.

DEAD Box Protein 5 Inhibits Liver Tumorigenesis by Stimulating Autophagy via Interaction with p62/SQSTM1.

Journal: Hepatology (Baltimore, Md.)
Published: June 08, 2018
Showing 1-12 of 16

Last Updated: 09/26/2026